Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.

Authors:
Motta E; Camacho LAB; Cunha M; de Filippis AMB; Lima SMB and 14 more

Journal:
AIDS

Publication Year: 2023

DOI:
10.1097/QAD.0000000000003696

PMCID:
PMC10653289

PMID:
37650759

Journal Information

Full Title: AIDS

Abbreviation: AIDS

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest There are no conflicts of interest."

Evidence found in paper:

"L.E.C., L.A.B.C., B.G., S.W.C. conceived and designed the study. A.B.F., S.M.B.L., L.P., F.C., C.G., M.M., S.N., M.C.O.S., Y.S.M., A.S.A., N.S.A. contributed to the study implementation, data collection and laboratorial analysis. L.E.C., E.M., M.C., R.I.M., L.A.B.C. contributed to the statistical analysis and interpretation. E.M. and L.E.C. wrote the first draft and all authors reviewed and approved the final version of the report and the manuscript. This work was funded by National Council for Scientific and Technological Development – CNPq and by Presidência da Fundação Oswaldo Cruz/Vice Presidência de Pesquisa e Coleções Biológicas VPPCB/Fiocruz - Chamada CNPq/Fiocruz N° 16/2017- PROEP/PEC (# 420674/2017–9). This work was also supported by Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz) and Coordenação de Vigilância em Saúde e Laboratórios de Referência (CVSLR) / FIOCRUZ/ MS. B.G. acknowledges funding from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)."

Evidence found in paper:

"This study was approved by INI/Fiocruz Ethics Committee (CAAE: #67136517.9.0000.5262) and registered at Clinicaltrials.gov (NCT03132311). All participants provided written informed consent."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025